Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 441 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Recruiting

Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.

NCT06856213

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, A Coruña, Spain
  • Instituto Catalán de Oncología - Badalona Badalona, Barcelona, Spain
  • Instituto Catalán de Oncología - Hospital Duran i Reynals Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla (Santander) Santander, Cantabria, Spain
View all 17 locations
View Trial Details
Recruiting

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

NCT04777994

Conditions
Adenocarcinoma, Advanced Solid Tumor Cancer, Bronchial Neoplasms, +29 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 262698 Tucson, Arizona, United States
  • Yale University School of Medicine /ID# 225707 New Haven, Connecticut, United States
  • Johns Hopkins Hospital /ID# 254056 Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center /ID# 252009 Boston, Massachusetts, United States
View all 30 locations
View Trial Details
Recruiting

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

NCT06525220

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations
  • Site 164 Mobile, Alabama, United States
  • Site 36 La Jolla, California, United States
  • Site 27 Los Angeles, California, United States
  • Site 16 Palo Alto, California, United States
View all 205 locations
View Trial Details

Related conditions